Short Interest in TScan Therapeutics, Inc. (NASDAQ:TCRX) Expands By 95.5%
Short interest in TScan Therapeutics (NASDAQ:TCRX) nearly doubled in July, increasing by 95.5% to 1.38 million shares, representing approximately 2.3% of the company's stock. The stock opened at $0.74, near its 12-month low, as the company continues to report significant losses and weak revenue. …